PE-backed Advance Pharma to acquire Intercept’s Europe, Canada and non-U.S. businesses

Advanz Pharma, which is backed by Nordic Capital, has agreed to acquire Intercept Pharmaceutical Inc.'s business in Europe, Canada and all other markets outside of the U.S.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this